Ram Kumar

Ram Kumar

Auto-generated profile, based on publicly available information

Ram Kumar

APEX Centre, RAJUVAS, Bikaner, Rajasthan, India-334001

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2021 in Antiviral Research
Verified
Journal Article
Closed access
RKRam Kumar
Ram Kumar
NKNitin Khandelwal
Nitin Khandelwal
YCYogesh Chander
Yogesh Chander
HNHimanshu Nagori
Himanshu Nagori
AVAssim Verma
Assim Verma
NKNaveen Kumar
Naveen Kumar

17 August 2022 in Molecular Biology and Evolution
Verified
Journal Article
Open access
PDF file
YCYogesh Chander
Yogesh Chander
RKRam Kumar
Ram Kumar
AVAssim Verma
Assim Verma
NKNITIN KHANDELWAL
NITIN KHANDELWAL
HNHimanshu Nagori
Himanshu Nagori
NKNaveen Kumar
Naveen Kumar
Host-dependency factors have increasingly been targeted to minimize antiviral drug resistance. In this study, we have demonstrated that inhibition of p38 mitogen-activated protein kinase (a cellular protein) suppresses buffalopox virus (BPXV) protein synthesis by targeting p38-MNK1-eIF4E signaling pathway. In order to provide insights into the evolution of drug resistance, we selected resistant mutants by long-term sequential passages (P; n = 60) in the presence of p38 inhibitor (SB239063). The P60-SB239063 virus exhibited significant resistance to SB239063 as compared to the P60-Control virus. To provide mechanistic insights on the acquisition of resistance by BPXV-P60-SB239063, we generated p38-α and p38-ϒ (isoforms of p38) knockout Vero cells by CRISPR/Cas9-mediated genome editing. It was demonstrated that unlike the wild type (WT) virus which is dependent on p38-α isoform, the resistant virus (BPXV-P60-SB239063) switches over to use p38-ϒ so as to efficiently replicate in the target cells. This is a rare evidence wherein a virus was shown to bypass the dependency on a critical cellular factor under selective pressure of a drug.

16 September 2026 in Acta Veterinaria Hungarica
Verified
Journal Article
Closed access
PDF file
DSDisha Sanwal
Disha Sanwal
JKJai Prakash Kachhawa
Jai Prakash Kachhawa
MGMamta Gurjar
Mamta Gurjar
RSRajesh Singathia
Rajesh Singathia
SGSita Ram Gupta
Sita Ram Gupta
RKRam Kumar
Ram Kumar
Canine pyoderma is a common bacterial skin infection predominantly caused by Staphylococcus species. This study, conducted from June to December 2024, analysed 71 PCR-confirmed cases of staphylococcal pyoderma to investigate epidemiological and host-associated risk factors and antimicrobial resistance (AMR) patterns. Bacterial isolates from PCR-positive samples were identified using MALDI-TOF MS and tested for antimicrobial susceptibility. Of the cases analysed, 63.38% involved monomicrobial infections, whereas 36.62% were accounted for polymicrobial infections. Staphylococcus pseudintermedius and Staphylococcus aureus were the predominant pathogens in both infection types, occurring alone or in combination with Escherichia coli , Pseudomonas aeruginosa or Klebsiella pneumoniae . Polymicrobial infections were significantly associated with recurrent disease, longer disease duration, tissue invasion and allergic skin manifestations. Both major Staphylococcus species exhibited high resistance to β -lactams and third-generation cephalosporins, with notable interspecies differences in resistance to ceftizoxime, trimethoprim-sulfonamide, amikacin, enrofloxacin and clindamycin. Although overall AMR did not differ significantly between major staphylococci species associated to monomicrobial and polymicrobial infections, however isolates from polymicrobial cases showed a consistent trend toward higher resistance across multiple antimicrobial classes. The findings emphasise the complexity of canine pyoderma characterised by bacterial communities dominated by Staphylococcus pseudintermedius and the increasingly relevant Staphylococcus aureus with potential zoonotic implications. Routine species-level identification, culture-guided therapy and continuous AMR surveillance are crucial for effective treatment and antimicrobial stewardship within a One Health framework.